Status:
COMPLETED
Reduction of Smoking in Cardiac Disease Patients
Lead Sponsor:
National Institute on Drug Abuse (NIDA)
Conditions:
Cardiovascular Disease
Tobacco Use Disorder
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study evaluates the effect of smoking reduction vs usual care (quitting advice only) for individuals with peripheral arterial disease who smoke.
Detailed Description
This study randomly assigns smokers who do not have a quit date set to either a smoking reduction grop or usual care group. The smoking reduction group receives behavioral counseling on smoking reduct...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- To be included in the study, participants must have peripheral arterial disease (defined as ankle Brachial Index equal to or less than 0.85 or history of prior revascularization) and they must be daily smokers (defined as at least 1 cigarette, cigar, or tobacco pipe daily).
Exclusion
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2005
Estimated Enrollment :
152 Patients enrolled
Trial Details
Trial ID
NCT00469885
Start Date
January 1 2001
End Date
December 1 2005
Last Update
January 10 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Univeristy of Minnesota
Minneapolis, Minnesota, United States, 55404
2
Univerisity of Minnesota
Minneapolis, Minnesota, United States, 55414